Results 21 to 30 of about 4,744 (193)

Clinical implications of congenital interruption of inferior vena cava

Journal of the Formosan Medical Association, 2022
Background/purpose: Inferior vena cava (IVC) interruption is rare and can be detected through prenatal or postnatal imaging. It usually occurs in patients with heterotaxy syndrome with bilateral left-sidedness (left isomerism or polysplenia syndrome ...
Shyh-Jye Chen, Mei-Hwan Wu, Jou-Kou Wang
doaj   +3 more sources

Complete atrioventricular block in an adult with congenitally corrected transposition of the great arteries with interrupted inferior vena cava

Journal of Research in Medical Sciences, 2012
A 56-year-old man got admitted as he was suffering from dizziness for 3 days. Electrocardiogram (ECG) showed complete atrioventricular (AV) block with ventricular rhythm of 35/min. We found that he had no inferior vena cava (IVC) which drained into right
Namsik Yoon, Kye Hun Kim, Hyung Wook Park, Jeong Gwan Cho   +3 more
doaj   +1 more source

Transcatheter closure of patent ductus arteriosus and interruption of inferior vena cava with azygous continuation using an Amplatzer duct occluder II

Annals of Pediatric Cardiology, 2009
We report a case of transcatheter closure of patent ductus arteriosus using the new Amplatzer duct occluder II in an adult patient with interrupted inferior vena cava with azygous continuation via the femoral artery approach.
Koh Ghee, AI Mokthar Sharifah, Hamzah Amir, Kaur Jasvinder   +3 more
doaj   +1 more source

Percutaneous closure of patent ductus arteriosus via internal jugular vein in patient with interrupted inferior vena cava

Annals of Pediatric Cardiology, 2009
Transcatheter closure of patent ductus arteriosus (PDA) using various occluders and coils via femoral vein is a well established therapeutic option.
Patel Nehal, Madan Tarun, Panchal Amar, Thakkar Bhavesh   +3 more
doaj   +1 more source

A remarkable case report of an interrupted inferior vena cava with hemiazygos and transhepatic continuation. [PDF]

Acta Biomed, 2023
Inferior vena cava (IVC) interruption with azygos/hemiazygos continuation is an extremely uncommon congenital vascular anomaly, which may present with multiple variants.
Masino F, Muscatella G, Montatore M, Gifuni R, Guglielmi G.   +4 more
europepmc   +2 more sources

A case report of an interrupted inferior vena cava and azygos continuation: implications for preoperative screening in minimally invasive cardiac surgery. [PDF]

Eur Heart J Case Rep, 2021
Background: Femoral cannulation is commonly used in minimally invasive cardiac surgery to establish extracorporeal circulation. We present a case with a finding that should be evaluated when screening candidates for minimally invasive cardiac surgery ...
Knol WG, Oei FB, Budde RPJ, Ter Horst M.
europepmc   +3 more sources

Evolving hemodynamics in Fontan circulation: age-driven insights in patients with interrupted inferior vena cava and hepatoazygos shunt [PDF]

American Journal of Physiology - Heart and Circulatory Physiology
Kannojiya V, Sahni A, Eickhoff E, Zacharia N, St Clair N, Schulz N, Hammer PE, Del Nido PJ, Rathod RH, Hoganson DM, Govindarajan V.   +10 more
exaly   +2 more sources

Recurrent atrial fibrillation ablation in a patient with an interrupted inferior vena cava and persistent left superior vena cava using pulsed field ablation [PDF]

HeartRhythm Case Reports
Kennosuke Yamashita, Yohei Kikuchi
exaly   +2 more sources

Successful catheter ablation of persistent atrial fibrillation and common atrial flutter in a patient with dextrocardia, situs inversus, and interrupted inferior vena cava with azygos continuation [PDF]

HeartRhythm Case Reports, 2021
Akiko Masumoto, , Yasuhiro Sasaki
exaly   +2 more sources

Interleukin‐18 signaling promotes activation of hepatic stellate cells in mouse liver fibrosis

Hepatology, EarlyView., 2022
Interleukin‐18 signaling promotes activation of hepatic stellate cells in mouse liver fibrosis. Abstract Background and Aims Nucleotide‐binding oligomerization domain‐like receptor‐family pyrin domain‐containing 3 (NLRP3) inflammasome activation has been shown to result in liver fibrosis.
Jana Knorr, Benedikt Kaufmann, Maria Eugenia Inzaugarat, Theresa Maria Holtmann, Lukas Geisler, Jana Hundertmark, Marlene Sophia Kohlhepp, Laela M. Boosheri, Daisy R. Chilin‐Fuentes, Amanda Birmingham, Kathleen M. Fisch, Joel D. Schilling, Sven H. Loosen, Christian Trautwein, Christoph Roderburg, Münevver Demir, Frank Tacke, Hal M. Hoffman, Ariel E. Feldstein, Alexander Wree   +19 more
wiley   +1 more source